Renate Kruschitz

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis

Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association

Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency

Feasibility and Efficacy of an Isocaloric High-Protein vs. Standard Diet on Insulin Requirement, Body Weight and Metabolic Parameters in Patients with Type 2 Diabetes on Insulin Therapy